Loading…
Standard BioTools Inc. (LAB) Price Prediction 2026–2050
Rank #3310NASDAQBearish
$0.7947
+2.59% (24h)
Standard BioTools Inc. (LAB) Forecast Summary
Standard BioTools Inc. is projected to rise to $0.9198 by 2027, a +16% move from its current price of $0.7947. LAB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Healthcare
Live market data via Yahoo Finance · updated 7/29/2026
Market Cap
$311.1M
24h Volume
$15.04M
Shares Outstanding
391.46M LAB
All-Time High
$27.48
Green Days (30d)
12/30
Volatility (30d)
4.68%
Standard BioTools Inc. (LAB) Price Prediction Summary
LAB Short-Term Price Forecast
Next 7 days
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 30 | $0.7586 | $0.7958 | $0.8349 | +0.14% |
| Jul 31 | $0.7447 | $0.7969 | $0.8528 | +0.28% |
| Aug 1 | $0.7345 | $0.798 | $0.8671 | +0.42% |
| Aug 2 | $0.7261 | $0.7991 | $0.8795 | +0.56% |
| Aug 3 | $0.7189 | $0.8003 | $0.8908 | +0.70% |
| Aug 4 | $0.7126 | $0.8014 | $0.9012 | +0.84% |
| Aug 5 | $0.7069 | $0.8025 | $0.911 | +0.98% |
Next 7 weeks
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7069 | $0.8025 | $0.911 | +0.98% |
| Week 2 | $0.6773 | $0.8103 | $0.9695 | +1.97% |
| Week 3 | $0.6569 | $0.8183 | $1.02 | +2.97% |
| Week 4 | $0.6412 | $0.8263 | $1.06 | +3.98% |
| Week 5 | $0.6284 | $0.8344 | $1.11 | +4.99% |
| Week 6 | $0.6176 | $0.8426 | $1.15 | +6.02% |
| Week 7 | $0.6083 | $0.8508 | $1.19 | +7.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
What is Standard BioTools Inc. (LAB)?
Standard BioTools Inc. develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.
It sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc.
in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Standard BioTools Inc. Price Prediction Overview
Standard BioTools Inc. (LAB) is a healthcare company focused on proteomics and genomics instrumentation and related products. The stock is currently priced at $0.7746 and has a market cap of $303.23M, with a market rank of 3321.
The stock’s all‑time high is $27.48 and its all‑time low is $0.0742, illustrating a wide historical trading range. The shares show high volatility, with an annualized volatility of 90%. The near‑term outlook combines a muted start with potential for longer‑term upside as reflected in the forecast path.
LAB Market & Technical Analysis
LAB Key Price Levels
Strong Support−53.3%
$0.3714
A major floor 53.3% below — a decisive break under it would weaken the trend.
Current Support−8.1%
$0.73
The nearest floor, 8.1% below — buyers have tended to step in here.
Current Resistance+18.3%
$0.94
The nearest ceiling, 18.3% above — a clean break opens room to run.
Strong Resistance+662.8%
$6.06
A major ceiling 662.8% above — clearing it would confirm fresh momentum.
Key LAB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
LAB Market Analysis
Trend ConsensusBearish
Bullish share of indicators18%
Timeframe AlignmentWeak
Price above 0/12 moving averages0%
Risk AssessmentHigh
~92% annualised volatility76%
Momentum (RSI)Sellers
RSI 41 — buying vs selling pressure41%
A snapshot of LAB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
LAB Indicator Summary
Strong Sell
Based on 26 indicators
- Buy
- 4
- Neutral
- 4
- Sell
- 18
Bearish18% BullishBullish
Indicators computed on daily closing prices.
Moving Averages
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.836 | Sell | $0.8241 | Sell |
| MA 10 | $0.846 | Sell | $0.8415 | Sell |
| MA 20 | $0.8595 | Sell | $0.8933 | Sell |
| MA 50 | $1.34 | Sell | $1.20 | Sell |
| MA 100 | $1.50 | Sell | $1.26 | Sell |
| MA 200 | $0.8254 | Sell | $1.08 | Sell |
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.27 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -163.25 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | -18.09 | Sell |
| Bollinger %B (20,2) | 0.01 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.97 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 38.10 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 0.82 | Sell |
| ADX (14) | 17.07 | Neutral |
| ATR (14) | 0.08 | Info |
Pivot Levels
- S3$0.4767
- S2$0.6033
- S1$0.6867
- Pivot$0.8133
- R1$0.8967
- R2$1.02
- R3$1.11
Near‑term the technical picture is Bearish. RSI14 is 40, indicating modest momentum downside. The stock trades below key moving averages, with SMA50 at $0.925 and SMA200 at $1.14, suggesting continued pressure from intermediate to longer time horizons.
Support sits at $0.73 and resistance at $0.94, creating a tight range for near‑term action. The 30‑day range spans from $0.5648 to $1.06, underscoring recent volatility and the potential for swift moves between support and resistance.
Standard BioTools Inc. (LAB) Price Prediction 2026–2050
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.73 | $0.7947 | $1.29 | 0% | Neutral | |
| $0.6829 | $0.9198 | $1.34 | +16% | Neutral | |
| $0.634 | $0.9012 | $1.39 | +13% | Neutral | |
| $0.6544 | $0.9735 | $1.57 | +23% | Bullish | |
| $0.641 | $0.9934 | $1.66 | +25% | Bullish | |
| $0.8191 | $1.32 | $2.28 | +66% | Bullish | |
| $0.9136 | $1.52 | $2.71 | +92% | Bullish | |
| $0.9082 | $1.57 | $2.86 | +97% | Bullish | |
| $0.8998 | $1.61 | $3.00 | +102% | Bullish | |
| $0.7984 | $1.47 | $2.81 | +85% | Bullish | |
| $1.01 | $2.18 | $4.55 | +174% | Bullish | |
| $2.57 | $5.71 | $13.14 | +619% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
Standard BioTools Inc. (LAB) 2026 Monthly Forecast
Current Price $0.7947Range $0.73 – $1.290% ROI
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.73 | $0.7947 | $0.9396 | +0.00% |
| August 2026 | $0.7091 | $0.8467 | $1.05 | +6.54% |
| September 2026 | $0.7447 | $0.9023 | $1.14 | +6.57% |
| October 2026 | $0.7373 | $0.904 | $1.16 | +0.18% |
| November 2026 | $0.7447 | $0.9221 | $1.20 | +2.01% |
| December 2026 | $0.7844 | $0.9802 | $1.29 | +6.30% |
Click any year to see its month-by-month LAB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Standard BioTools Inc. (LAB) Year-by-Year Price Prediction
Standard BioTools Inc. (LAB) Price Prediction 2026
Expect LAB to range from $0.73 to $1.29 through 2026. The $0.7947 average target implies a 0% move from current prices. Price action looks broadly range-bound.
Standard BioTools Inc. (LAB) Price Prediction 2027
The LAB price prediction for 2027 points to an average of $0.9198 (low $0.6829, high $1.34) — a potential gain of +16% on today's $0.7947. A consolidation phase looks the most probable path here.
Standard BioTools Inc. (LAB) Price Prediction 2028
In 2028, LAB is projected to trade between $0.634 and $1.39, averaging $0.9012 — a potential gain of +13% from today's $0.7947. That is -2% versus the projected 2027 average. Price action looks broadly range-bound.
Standard BioTools Inc. (LAB) Price Prediction 2029
Standard BioTools Inc.'s 2029 outlook centres on $0.9735, within a $0.6544 to $1.57 range. That is up +8% on the projected 2028 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2030
By 2030, LAB could reach as high as $1.66, with a base case around $0.9934 and support toward $0.641 — roughly +25% from $0.7947. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2031
Expect LAB to range from $0.8191 to $2.28 through 2031. The $1.32 average target implies a +66% move from current prices. That is up +33% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2032
The LAB price prediction for 2032 points to an average of $1.52 (low $0.9136, high $2.71) — a potential gain of +92% on today's $0.7947. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2033
In 2033, LAB is projected to trade between $0.9082 and $2.86, averaging $1.57 — a potential gain of +97% from today's $0.7947. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2034
Standard BioTools Inc.'s 2034 outlook centres on $1.61, within a $0.8998 to $3.00 range. That is up +2% on the projected 2033 average. That marks a +102% change versus current levels. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2035
By 2035, LAB could reach as high as $2.81, with a base case around $1.47 and support toward $0.7984 — roughly +85% from $0.7947. Buyers look set to stay in control over this stretch.
Standard BioTools Inc. (LAB) Price Prediction 2040
Expect LAB to range from $1.01 to $4.55 through 2040. The $2.18 average target implies a +174% move from current prices. That is up +48% on the projected 2035 average. Momentum favours further upside here.
Standard BioTools Inc. (LAB) Price Prediction 2050
The LAB price prediction for 2050 points to an average of $5.71 (low $2.57, high $13.14) — a potential gain of +619% on today's $0.7947. Buyers look set to stay in control over this stretch.
Investment Calculator
Scenario
Investing $1,000 in LAB today (≈ 1,258.336479 LAB) could be worth
$7,188.92
+$6,188.92 (+619%) by 2050 · US Dollar
Based on the average projected LAB price of $5.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
LAB tools
If You Had Invested in Standard BioTools Inc.
See what a past investment in LABwould be worth at today's price.
Invested
$1,000 invested in LAB on Jul 28, 2025 (≈ 704.225373 LAB) would be worth
$559.65
-$440.35 (-44.0%) today · 0.56× · US Dollar
Based on a LAB entry price of $1.42 vs. today's $0.7947.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.85 | $934.94 | -6.5% |
| 1 month ago | $0.73 | $1,088.63 | +8.9% |
| 3 months ago | $0.706917 | $1,124.18 | +12.4% |
| 6 months ago | $0.15687 | $5,065.97 | +406.6% |
| 1 year ago | $1.42 | $559.65 | -44.0% |
| All time (5.0y) ago | $7.41 | $107.25 | -89.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Will LAB reach a target price?
Enter a price to see how it sits against our LAB forecast.
Likely(2.0× current price)
Our base-case forecast reaches $1.60 around 2034.
Implied market cap at $1.60: $626.34M
Standard BioTools Inc. Long-Term Forecast (2026–2050)
The multi‑year forecast shows a bullish trajectory with rising averages and expanding price potential. In 2026 the Avg is $0.7746 with a min of $0.73 and a max of $1.26, and it carries a Neutral sentiment. By 2029 the Avg rises to $0.9521 with a max of $1.54 and a Bullish sentiment, and the path continues higher thereafter.
In 2030 the Avg is projected at $0.9676 with a max of $1.62 and a Bullish sentiment, yielding an ROI of 24.9%. Subsequent years display ongoing upside: 2031 Avg $1.29 (ROI 66.3%), 2032 Avg $1.49 (ROI 92.5%), 2033 Avg $1.53 (ROI 97.5%), 2034 Avg $1.57 (ROI 102.8%), and 2035 Avg $1.44 (ROI 85.9%). By 2040 the Avg reaches $2.13 (ROI 175.2%), and by 2050 the Avg is $5.59 (ROI 621.6%) with a max of $12.86 and a Bullish sentiment.
These figures illustrate a long‑run appreciation possibility, though the path is uncertain and subject to market risk. The forecasts include various yearly min/max values and rising sentiment toward later years.
LAB Frequently Asked Questions
Tap a question to reveal the answer.
What will Standard BioTools LAB be worth in 2026?
The 2026 forecast shows avg price $0.7746 with a range of $0.73 to $1.26, ROI 0%, sentiment NEUTRAL.
Is LAB a good investment according to the forecast?
The outlook is Neutral in 2026–2028, turning Bullish from 2029 onward with rising averages and ROIs, e.g., 2030 Avg $0.9676 and ROI 24.9%; 2050 Avg $5.59 with ROI 621.6% (max $12.86).
Can LAB reach $2 by 2032?
Yes. The 2032 forecast shows max $2.65, avg $1.49, min $0.8933, ROI 92.5%, sentiment BULLISH.
What are LAB's all‑time high and all‑time low?
All‑Time High $27.48; All‑Time Low $0.0742.
What is LAB's current price and its 30‑day range?
Current price is $0.7746. The 30‑day range is $0.5648 to $1.06.
Standard BioTools Inc. Community Discussion
0Share your Standard BioTools Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.